Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held N/A

Joseph S Zakrzewski Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 19 2021
SELL
Disposition due to a tender of shares in a change of control transaction
-
34,499 Reduced 100.0%
0 Common Stock
Apr 05 2021
SELL
Open market or private sale
$1,412,900 $141.29 p/Share
10,000 Reduced 22.47%
34,499 Common Stock
Apr 05 2021
BUY
Exercise of conversion of derivative security
$241,100 $24.11 p/Share
10,000 Added 18.35%
44,499 Common Stock
Apr 01 2021
SELL
Open market or private sale
$1,344,400 $134.44 p/Share
10,000 Reduced 22.47%
34,499 Common Stock
Apr 01 2021
BUY
Exercise of conversion of derivative security
$241,100 $24.11 p/Share
10,000 Added 18.35%
44,499 Common Stock
Jan 29 2021
BUY
Grant, award, or other acquisition
-
1,622 Added 4.49%
34,499 Common Stock

Also insider at

AMRN
AMARIN CORP PLCUK Healthcare
SGMO
SANGAMO THERAPEUTICS, INC Healthcare
CYT
Cyteir Therapeutics, Inc. Healthcare
ANTX
AN2 Therapeutics, Inc. Healthcare
JSZ

Joseph S Zakrzewski

Director
Brisbane, CA

Track Institutional and Insider Activities on XLRN

Follow ACCELERON PHARMA INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XLRN shares.

Notify only if

Insider Trading

Get notified when an Acceleron Pharma Inc insider buys or sells XLRN shares.

Notify only if

News

Receive news related to ACCELERON PHARMA INC

Track Activities on XLRN